Coya Therapeutics Inc (COYA) Stock Price

4.94 ▲ +0.05 (+1.02%)
Open: 4.955 Vol: 3.22K Day's range: 4.85 - 5.005 Sep 21, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
COYA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 4.94▼ 4.93▲ 4.91▲ 4.74▲ 4.71▲
MA10 4.94▲ 4.91▲ 4.93▲ 4.65▲ 4.65▲
MA20 4.93▲ 4.94▲ 4.86▲ 4.68▲ 4.82▲
MA50 4.92▲ 4.79▲ 4.69▲ 4.61▲ 4.98▼
MA100 4.95▼ 4.68▲ 4.62▲ 4.74▲ 5.55▼
MA200 4.80▲ 4.64▲ 4.72▲ 4.79▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.009▼ -0.005▼ 0.035▲ 0.028▲
RSI 52.309▲ 56.991▲ 59.203▲ 57.709▲ 51.862▲
STOCH 50.708     48.130     34.124     64.476     51.233    
WILL %R -52.000     -41.935     -43.284     -19.205▲ -53.928    
CCI 73.684     59.525     16.028     184.903▲ 21.237    
Latest Filters Detected On COYA
▲ MACD $COYA MACD(12,26,9) Crossed Above Zero Set Alert
CDL $COYA Doji Candlestick Pattern Detected Set Alert
Coya Therapeutics Inc News
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Tuesday, September 15, 2026 01:00 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with ...
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS ...
Tuesday, September 08, 2026 05:00 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, today announced the publication of ...
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Monday, June 15, 2026 01:00 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with ...
COYA historical stock data
date open high low close volume
21/09/26 4.955 5.015 4.85 4.94 163,095
18/09/26 4.76 5.085 4.705 4.89 403,456
17/09/26 4.54 4.89 4.54 4.76 221,539
16/09/26 4.66 4.7193 4.46 4.46 129,322
15/09/26 4.62 4.72 4.49 4.65 215,172
14/09/26 4.39 4.78 4.33 4.64 201,468
11/09/26 4.59 4.66 4.37 4.38 139,342
10/09/26 4.61 4.62 4.455 4.52 93,464
09/09/26 4.55 4.695 4.53 4.61 77,819
08/09/26 4.82 4.82 4.595 4.61 98,353
Quote Details
52wk Low:3.71
52wk High:7.75
Vol:3.22K
Avg Vol(3m):3.3M
1Y Chng:-22.69%
1M Chng:+6.47%
Add to Watch List
More Information
Index US Composite
Market Cap. 111.66M